Menu Back toEvolving-Roles-and-Responsibilities-for-Medical-Affairs-Professionals

DIA 2018 Global Annual Meeting

Evolving Roles and Responsibilities for Medical Affairs Professionals

    Session Chair(s)
      Dannis  Chang, PharmD

      Dannis Chang, PharmD

      • Strategic Program Lead, Medical Affairs, Business Systems Design
      • Genentech, A Member of the Roche Group, United States
    This forum will discuss how with the recent changes of regulatory and marketing practices, safety surveillance, cost, and delivery of information, the traditional medical affairs paradigm has certainly evolved from a supportive entity to the central focal point with new emerging roles and responsibilities that will continue to evolve in the coming years to communicate more effectively both internally and externally with healthcare providers to better demonstrate the value of their medicines.
    Learning Objective : Discuss the current and future state of medical affair and how different roles within the organization can support advancements patient care; Assess new emerging roles that are implemented within medical affairs; Explore innovative new strategies that will empower Medical Affairs professionals to meet future challenges and opportunities in healthcare; Identify areas to develop skill sets for new opportunities in medical affairs.
      Suzanne  Soliman, PharmD, RPh

      To be determined

      Suzanne Soliman, PharmD, RPh

      • Chief Academic Officer
      • Accreditation Council for Medical Affairs, United States
      Ketra  Bouvier, BSN, RN

      To be determined

      Ketra Bouvier, BSN, RN

      • Manager, Global Medical Information
      • Eli Lilly and Company, United States
      Sotirios G. Stergiopoulos, MD

      To be determined

      Sotirios G. Stergiopoulos, MD

      • Chief Medical Officer, Senior Vice President and Head of Global Medical Affairs
      • IPSEN , United States